High Tide to Acquire 51% Stake in Remexian Pharma

MT Newswires Live
08/14

High Tide (HITI) said Thursday it agreed to acquire a 51% stake in Remexian Pharma for a preliminary estimated purchase price of 27.2 million euros ($31.8 million), subject to adjustments.

The consideration will consist of 42% in High Tide common shares, 29% in cash, and 29% via loans from the sellers, the company said.

The company said the deal, expected to close in the coming weeks, implies an enterprise valuation of 53.4 million euros.

High Tide added that it will have an option to buy the remaining stake in Remexian.

Shares of High Tide were up more than 3% in recent premarket activity Thursday.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10